ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) Gross profit 2021–2025
ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) annual gross profit history from SEC filings — each fiscal year as reported.
$339.4MFY2025 · since FY2021: $0 → $339.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $339.4M | +91.3% |
| FY2024 | $177.4M | +224.8% |
| FY2023 | $54.6M | +1762.9% |
| FY2022 | $2.9M | — |
| FY2021 | $0 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ARQT financial trends
ARQT RevenueARQT Net incomeARQT Net marginARQT Gross marginARQT Operating incomeARQT Operating marginARQT Operating cash flowARQT Free cash flowARQT Capital expendituresARQT Return on equityARQT Stock buybacksARQT Dividends paidARQT Total assetsARQT Total liabilitiesARQT Shareholders’ equityARQT overview →